Company news
Bloomage Biotechnology Corp. Ltd. Class A (SSE:688363) news
Bloomage Biotechnology Corp. Ltd. Class A news releases on 6ix. Latest, Sep 22, 2026: "Bloomage Biotechnology Corporation Limited"Announcement on Departure…
Press releases & updates
"Bloomage Biotechnology Corporation Limited"Announcement on Departure of Core Technical Personnel and Newly Designated Core Technical Personnel
September 21, 2026
"Bloomage Biotechnology Corporation Limited"Semi-annual Evaluation Report on the 2026 "Corporate Value and Return Enhancement" Special Action Plan
August 27, 2026
"Bloomage Biotechnology Corporation Limited"Announcement on Implementation of Dividend Distribution for 2025
July 6, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
June 16, 2026
Indicative Announcement on Change in Controlling Shareholder and Persons Acting in Concert's Equity Crossing an Integer Multiple of 5%
May 29, 2026
Notice on Convening the 2025 Annual General Meeting
May 25, 2026
Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction
May 13, 2026
Announcement on Controlling Shareholder's Performance of a Donation Agreement and Non-gratis Donation of Partial Shares
May 11, 2026
Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
April 30, 2026
Announcement on Requesting the General Meeting to Authorize Board of Directors to Conduct Issuance of Shares to Specific Objects by Summary Procedure
April 29, 2026
Announcement on 2025 Annual Profit Distribution Plan
April 22, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Announcement on the Estimated Amount of Daily Related Party Transactions in 2026
February 11, 2026
Announcement on the Resignation of Core Technical Personnel
February 6, 2026
Announcement on Expected Increase in Performance for 2025
January 30, 2026
Announcement on Result of Shareholding Reduction by Shareholders
January 16, 2026
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 5% Scale
January 8, 2026
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
November 27, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 25, 2025
Announcement on Shareholding Reduction Plan for Shareholders
November 4, 2025
Announcement on Settlement of Arbitration Matters between the Holding Subsidiary and Medytox
October 29, 2025
Announcement on Provision for Large-amount Assets Impairment for Q3 2025
October 28, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
October 27, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025
October 10, 2025
Announcement on Completion and Share Increase Results of the Share Increase Plan for Controlling Shareholders
September 30, 2025
Indicative Announcement on Progress of Shareholding Increase by Controlling Shareholder and Change in Shareholding Reaching Integer Multiples of 5%
September 23, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 17, 2025
Announcement on Progress in Shareholding Increase by Controlling Shareholder and Amount Exceeding the Lower Limit of the Increase Range
September 7, 2025
Announcement on Progress in Shareholding Increase by Controlling Shareholder and Completion of Half of the Planned Increase Amount
August 29, 2025
Announcement on the 1st Share Increase by Controlling Shareholder and Progress of the Share Increase Plan
August 28, 2025
Semi-annual Assessment Report on "Corporate Value and Return Enhancement" Action Plan 2025
August 26, 2025
Announcement on Receiving Commitment Letter on Special Loan for Controlling Shareholder's Share Increase
August 13, 2025
Announcement on Voluntary Disclosure of Completion of Medical Device Master File Registration for Sodium Chondroitin Sulfate Produced by Fermentation
August 11, 2025
Announcement on Shareholding Increase Plan of Controlling Shareholder
August 7, 2025
Announcement on Electing Employee Representative Director of the 3rd Board of Directors
July 16, 2025
Announcement on Voluntary Disclosure of Subsidiary Passing On-site Inspection by FDA
July 9, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 7, 2025
Announcement on Obtaining Government Subsidies
June 30, 2025
Announcement on Resolution of the 2024 Annual General Meeting
June 11, 2025
Notice on Convening the 2024 Annual General Meeting
May 20, 2025
Announcement on the Term Change and Election of the Board of Directors
May 19, 2025
Announcement on Provision for Large-amount Assets Impairment for Q1 2025
April 25, 2025
Announcement on Attending Annual Collective Performance Briefing for STAR Market Enterprises in Biological Products and CXO Industries in 2024
April 21, 2025
Announcement on Estimated Daily Related Party Transactions in 2025
April 10, 2025
Announcement on Adjustment and Appointment of Senior Managers
March 19, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on the Expiration of the Share Reduction Plan of Shareholders and the Results of Share Reduction
January 27, 2025
Annual Earnings Preannouncement for 2024
January 24, 2025
Announcement on the Retirement of Deputy General Manager and Key Technical Personnel
January 2, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2024
December 2, 2024